HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact
Author Information
Author(s): Kenneth Lichtenstein, Ashok Balasubramanyam, Rajagopal Sekhar, Eric Freedland
Primary Institution: University of Colorado Infectious Disease Group Practice
Hypothesis
What is the definition and clinical impact of HIV-associated adipose redistribution syndrome (HARS)?
Conclusion
HARS is a specific form of HIV-associated lipodystrophy characterized by abnormal accumulation of trunk fat and is associated with metabolic disorders similar to those of metabolic syndrome.
Supporting Evidence
- HARS is estimated to occur in up to 32% of HIV patients.
- Patients with HARS may experience health risks similar to those of metabolic syndrome.
- Techniques to detect HARS include physician assessments and radiologic methods.
Takeaway
Some people with HIV get a condition called HARS where they gain fat in their belly and back, which can be unhealthy.
Methodology
The study reviewed existing literature and data on HARS, including prevalence and health risks associated with the condition.
Potential Biases
There may be bias in case definitions that exclude certain patients, potentially underestimating the prevalence of HARS.
Limitations
The study faced challenges in defining HARS due to varying case definitions and detection methods.
Participant Demographics
The study included HIV-infected patients, with a significant portion being treated with protease inhibitors.
Statistical Information
P-Value
0.454
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website